Conference Coverage

Physical therapy, exercise still relevant for ankylosing spondylitis


 

REPORTING FROM SPARTAN

In the era of biologics, physical therapy still has a place in the treatment of patients with ankylosing spondylitis, according to Angelo Papachristos, an advanced physiotherapist at St. Michaels Hospital in Toronto.

Speaking in an education session at the annual meeting of the Spondyloarthritis Research and Treatment Network (SPARTAN), Mr. Papachristos said that therapy should be introduced at diagnosis, individualized, and constantly reevaluated.

“There is no one recommendation,” he said. “Therapy should be monitored and adjusted over time depending on how the patient responds.”

Mr. Papachristos drew attention to two portions of recommendations from the American College of Sports Medicine (ACSM).

First, that scientific evidence demonstrates that the beneficial effects of exercise are indisputable and that the benefits far outweigh the risks.

Second, that a program of regular exercise that includes cardiorespiratory, resistance, flexibility, and neuromotor aspects to improve and maintain fitness and health is essential for most adults.

How much exercise to prescribe and when to introduce exercise remains a question.

Pages

Recommended Reading

Flare of nonradiographic axial SpA occurs often after adalimumab withdrawal for remission
MDedge Internal Medicine
TNFi response evaluations may conflict when fibromyalgia, axial SpA coexist
MDedge Internal Medicine
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
MDedge Internal Medicine
TNF inhibitors curb spinal x-ray progression in ankylosing spondylitis
MDedge Internal Medicine
Role of musculoskeletal ultrasound expands in rheumatic diseases
MDedge Internal Medicine
Arthritis limits physical activity the most in the South
MDedge Internal Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Internal Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Internal Medicine
TB in 2017: Good news and bad news
MDedge Internal Medicine
MACE risk similar across arthritis subtypes
MDedge Internal Medicine